Similar articles

• Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.

  McClain RM. McClain RM. Prog Clin Biol Res. 1990;331:345-65. Prog Clin Biol Res. 1990. PMID: 2156272 Review. No abstract available.
• Nutrition and enzyme inducers in liver tumor promotion in human and rat.

  McLean EM, Driver H, McDanell R. McLean EM, et al. Bull Cancer. 1990;77(5):505-8. Bull Cancer. 1990. PMID: 2400825
• Phenobarbital mouse liver tumors: implications of hepatic tumor promotion for cancer risk assessment.

  McClain RM. McClain RM. Prog Clin Biol Res. 1995;391:325-36. Prog Clin Biol Res. 1995. PMID: 8532725 Review. No abstract available.
• Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.

  Hard GC, Iatropoulos MJ, Jordan K, Radi L, Kaltenberg OP, Imondi AR, Williams GM. Hard GC, et al. Cancer Res. 1993 Oct 1;53(19):4534-41. Cancer Res. 1993. PMID: 8402624
• Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.

  Carthew P, Martin EA, White IN, De Matteis F, Edwards RE, Dorman BM, Heydon RT, Smith LL. Carthew P, et al. Cancer Res. 1995 Feb 1;55(3):544-7. Cancer Res. 1995. PMID: 7834623